Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The Schools Commissioner has admitted that consideration of free school proposals in the early days of the programme was not as robust as it could have been and that free schools may well have opened in areas which already had surplus places and could lead to free schools failing as they are unable to attract sufficient numbers of pupils. The Commissioner noted that 80% of free schools were now being opened in areas of basic need and that rigorous criteria were now applied to proposals to target new provision to those areas which required additional provision or where there was insufficient good or outstanding provision already. Critics of the programme have suggested that a more transparent system is required.
The free school programme’s aim was to provide a method by which new schools could be opened as a result of parental demand and to provide outstanding provision in areas of need. The robust criteria now being applied to proposals should go some way to meeting these aims but only time will tell how effective the programme has been in raising standards overall.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up